Two hereditary syndromes, lymphedema-distichiasis (LD) syndrome and blepharo-chelio-dontic (BCD) syndrome include the aberrant growth of eyelashes from the meibomian glands, known as distichiasis. LD is an autosomal dominant syndrome primarily characterized by distichiasis and the onset of lymphedema usually during puberty. Mutations in the forkhead transcription factor FOXC2 are the only known cause of LD. BCD syndrome consists of autosomal dominant abnormalities of the eyelid, lip, and teeth, and the etiology remains unknown. In this report, we describe a proband that presented with distichiasis, microcephaly, bilateral grade IV vesicoureteral reflux requiring ureteral re-implantation, mild intellectual impairment and apparent glomuvenous malformations (GVM). Distichiasis was present in three generations of the proband's maternal side of the family. The GVMs were severe in the proband, and maternal family members exhibited lower extremity varicosities of variable degree. A GLMN (glomulin) gene mutation was identified in the proband that accounts for the observed GVMs; no other family member could be tested. TIE2 sequencing revealed no mutations. In the proband, an additional submicroscopic 265 kb contiguous gene deletion was identified in 16q24.3, located 609 kb distal to the FOXC2 locus, which was inherited from the proband's mother. The deletion includes the C16ORF95, FBXO31, MAP1LC3B, and ZCCHC14 loci and 115 kb of a gene desert distal to FOXC2 and FOXL1. Thus, it is likely that the microcephaly, distichiasis, vesicoureteral, and intellectual impairment in this family may be caused by the deletion of one or more of these genes and/or deletion of distant cis-regulatory elements of FOXC2 expression.
Two hereditary syndromes, lymphedema-distichiasis (LD) syndrome and blepharo-chelio-dontic (BCD) syndrome include the aberrant growth of eyelashes from the meibomian glands, known as distichiasis. LD is an autosomal dominant syndrome primarily characterized by distichiasis and the onset of lymphedema usually during puberty. Mutations in the forkhead transcription factor FOXC2 are the only known cause of LD. BCD syndrome consists of autosomal dominant abnormalities of the eyelid, lip, and teeth, and the etiology remains unknown. In this report, we describe a proband that presented with distichiasis, microcephaly, bilateral grade IV vesicoureteral reflux requiring ureteral re-implantation, mild intellectual impairment and apparent glomuvenous malformations (GVM). Distichiasis was present in three generations of the proband's maternal side of the family. The GVMs were severe in the proband, and maternal family members exhibited lower extremity varicosities of variable degree. A GLMN (glomulin) gene mutation was identified in the proband that accounts for the observed GVMs; no other family member could be tested. TIE2 sequencing revealed no mutations. In the proband, an additional submicroscopic 265 kb contiguous gene deletion was identified in 16q24.3, located 609 kb distal to the FOXC2 locus, which was inherited from the proband's mother. The deletion includes the C16ORF95, FBXO31, MAP1LC3B, and ZCCHC14 loci and 115 kb of a gene desert distal to FOXC2 and FOXL1. Thus, it is likely that the microcephaly, distichiasis, vesicoureteral, and intellectual impairment in this family may be caused by the deletion of one or more of these genes and/or deletion of distant cis-regulatory elements of FOXC2 expression.
INTRODUCTION
Distichiasis is defined as a second row of eyelashes arising from the meibomian glands of the eyelid [Brooks et al., 2003] . Distichiasis can be inherited in an autosomal dominant manner as part of lymphedema-distichiasis syndrome (LD; OMIM 153400) or blepharo-chelio-dontic syndrome (BCD; OMIM 119580). LD is characterized by onset of bilateral lower limb lymphedema at puberty and congenital distichiasis, as well as other less penetrant clinical associations including varicose veins, congenital heart disease, cleft palate, and ptosis [Fang et al., 2000; Bell et al., 2001; Erickson et al., 2001; Finegold et al., 2001; Brice et al., 2002] . FOXC2 mutations cause the majority of LD cases, although two LD families without FOXC2 mutations but with linkage to the FOXC2 region have been reported [Sholto-Douglas-Vernon et al., 2005] . Diagnostic criteria for BCD syndrome includes abnormalities of the eyelid (euryblepharon, ectropion of lower lid, distichiasis of the upper lid, lagophthalmia), lip (bilateral cleft lip and palate) and teeth (oligodontia and microdontia) [Gorlin et al., 1996] . To date, the molecular cause of BCD is unknown.
Vascular malformations are congenital lesions that exhibit a normal rate of endothelial cell proliferation, but result from inborn errors of vascular morphogenesis [Mulliken, 1988] . Vascular malformations are classified based on the affected vessel-type (artery, vein, capillary) and flow-characteristics (fast or slow) into venous malformations (VM), capillary malformations and arterial malformations. Some genetic factors responsible for vascular malformations have been elucidated [for review Brouillard and Vikkula, 2007] . Most VM are sporadic, but some hereditary VM exhibit autosomal dominant inheritance [Boon et al., 2004] . Cutaneomucosal venous malformations (VMCM) are composed of dilated vessels with thin walls and poor smooth muscle cell coverage [Vikkula et al., 1996; Boon et al., 2004] . Linkage analysis led to the identification of mutations in the receptor tyrosine kinase TIE-2 (TEK) gene as the cause of VMCM [Vikkula et al., 1996] . Glomuvenous malformations (GVM) are vascular anomalies characterized by venous-like channels surrounded by abnormal smooth muscle-like cells known as glomus cells [Boon et al., 2004] . GLMN gene mutations were identified as the cause of GVMs [Brouillard et al., 2002 [Brouillard et al., , 2005 .
Here, we report on a case that presented with distichiasis, microcephaly, bilateral grade IV vesicoureteral reflux, mild intellectual impairment, and GVMs. No lymphedema had developed in the proband and no FOXC2 coding exon mutations were detected. Clinical chromosomal microarray analysis identified a 16q24.3 submicroscopic contiguous gene deletion including the C16ORF95, FBXO31, MAP1LC3B, and ZCCHC14 loci. The deletion was further characterized by fluorescent in situ hybridization (FISH), and the breakpoints were identified and sequenced. There were 2 bp of homology at the breakpoints, suggesting the deletion was formed by a non-homologous end joining (NHEJ) or template switching mechanism. Further genetic testing of known VM gene candidates revealed that the proband was heterozygous for a known pathogenic 157delAAGAA GLMN mutation [Brouillard et al., 2002 [Brouillard et al., , 2005 . The 16q24.3 deletion may be a novel cause of a rare if not unique syndrome including distichiasis, microcephaly, bilateral grade IV vesicoureteral reflux, and intellectual impairment due to position effect on FOXC2 and/or deletion of one or more distal genes.
MATERIALS AND METHODS Ascertainment
The proband was referred to the University of Michigan Pediatric Genetics Clinic for evaluation of a potential vascular malformation syndrome and was evaluated by one of the authors (J.W.I.). The presence of distichiasis suggested that features of the proband may be caused by a FOXC2 mutation. Therefore, informed consent for DNA testing was obtained from the proband and family members in accordance with the guidelines of the University of Michigan Medical School Institutional Review Board.
MR Imaging
Imaging was performed on a 1.5 T MR (Sigma, GE Healthcare, Waukesha, WI). The MR images in Figure 3 were obtained under the following conditions: 3A-axial T1-weighted (TR 467 ms, TE 14 ms), 3B-Axial T2-weighted (TR 3,400 ms, TE 79 ms), 3C-Coronal short tau inversion recovery (TR 4,000 ms, TE 26.2 ms, TI 165 ms), 3D-Axial T1-weighted with fat saturation post-gadolinium (TR 210 ms, TE 3.5 ms), 3E-Coronal T1-weighted with fat saturation post-gadolinium (TR 255 ms, TE 3.3 ms).
DNA Isolation and Establishment of the LD-064 Cell Line
Genomic DNA was extracted from 5 ml blood samples using a guanidine HCl method for DNA extraction from blood [Ciulla et al., 1988] . The LD-064 cell line was established from a 5 ml blood sample from the proband using the lymphocyte separation medium (ICN, Aurora, OH) and immortalization with Epstein-Barr virus (EBV) [Gilbert, 2001] .
FOXC2, Glomulin, and TIE2 Mutation Screening FOXC2 was screened for mutations as previously described [Fang et al., 2000] . Deletion of the FOXC2 locus was tested for by FISH using BAC clone RP11-463O9 as probe. Sequencing of the GLMN and TIE2 genes was carried out as described [Vikkula et al., 1996; Brouillard et al., 2002] .
Chromosomal Analysis
The proband's karotype was evaluated by the University of Michigan Clinical Cytogenetics Laboratory. Genomic microarray analysis using a BAC array (v4.1) was performed on DNA samples from the proband, the brother and mother of the proband at Baylor College of Medicine.
FISH
BAC clones RP11-463O9, RP11-235F18, RP11-178L8, RP11-482M8, RP11-264L1 were purchased from CHORI BACPAC Resource Center (Oakland, CA). FISH probes were generated using the Roche Biotin Nick Translation Kit (Indianapolis, IN) with 1 mg BAC DNA. FISH was performed as previously described [Wilke et al., 1996] .
SNP Genotyping
SNPs surrounding the 16q24.3 deletion were chosen for genotyping using the UCSC genome browser and dbSNP [Sherry et al., 2001; Karolchik et al., 2003] . Primers for PCR were designed using Primer3 to flank the SNPs of interest [Rozen and Skaletsky, 2000] . All primers are listed in Table I . All PCRs were performed with Invitrogen Taq polymerase (Carlsbad, CA) using standard conditions (20 mM Tris-HCl pH 8.4, 50 mM KCl, 1.5 mM MgCl 2 , 0.2 mM dNTPs, 0.2 mM each sense and antisense primers) with a 60 C annealing temperature and an extension of 1 min for 30 cycles. PCR products were separated by gel electrophoresis and subsequently purified with the Zymoclean gel DNA recovery kit (Zymo Research; Orange, CA). PCR products were sequenced by the University of Michigan DNA Sequencing Core (http://seqcore. brcf.med.umich.edu/).
Inverse PCR
Inverse PCR was performed as previously described [Wei et al., 2001; Morrish et al., 2002] . Primers located distal to rs4843612 were chosen for inverse PCR using Primer3 [Rozen and Skaletsky, 2000] . Genomic DNA (5 mg) from the proband were digested with SspI, SphI, PstI, or HindIII and circularized with 3,200 units of T4 DNA Ligase from NEB (Ipswich, MA) in a final volume of 1 ml. The resulting ligation products were PCR-amplified using primers Inverse-F (5 0 -TTACGCATGCTGTTTGGAAA-3 0 ) and Inverse-R (5 0 -TGTGGTTTTGCCCTGGTCTT-3 0 ). PCR conditions were as follows: initial cycle of 95 C for 5 min, followed by 35 cycles of 30 sec at 94 C, 30 sec at 60 C, 15 min at 68 C, with a final step of 68 C for 10 min. PCR products were cloned into the Topo-XL cloning vector according to manufacturer's instructions (Invitrogen). Topo-XL 
clones were end sequenced with M13Forward and Reverse primers by the University of Michigan DNA Sequencing Core. The deletion breakpoints were confirmed by PCR amplification across the breakpoint junction in a multiplex-PCR reaction that also included amplification of the wild type allele. Genomic DNA was amplified by PCR using standard conditions with oligos Wt-
, an annealing temperature of 65 C and an extension time of 1 min for 35 cycles.
Copy Number Variation (CNV)
The Database of Genomic Variants (http://projects.tcag.ca/ variation/) was used to identify copy number variants in the 16q24.3 region.
RESULTS

Clinical Findings
The proband (Fig. 1 , III-2) was first seen at the University of Michigan at the age of 10 years and 2.5 months and was referred for evaluation of a possible vascular malformation syndrome and developmental delay. She was born at term after an uncomplicated pregnancy and weighed 2,325 g. Vascular malformations were noted at birth involving the right parietal area, upper left chest, left shoulder, left hand, and left leg. Bayley Scales of Infant Development II testing at 32 months resulted in a mental development index below 50 and an overall developmental age of 19 months. Receptive and expressive communication skills were at the 24-month level. The proband had a history of tympanostomy tube placement at 2 years of age followed by normal tympanograms and normal speech recognition threshold hearing testing. In the first 3 years, she required casting for positioning of the left foot followed by heel cord release surgery. Subsequently, at 12 years, she had right equinus contracture requiring heel cord lengthening surgery. Past medical history also includes diagnoses of attention deficit hyperactivity disorder, learning disabilities, mild intellectual impairment, and recurrent urinary tract infections with bilateral grade IV vesicoureteral reflux requiring bilateral ureteral reimplantation surgery. The proband's mother (Fig. 1 , II-2) also had a history of mental impairment and learning problems, which required special education services in school (formal testing was not performed). The proband, her mother and her maternal grandmother reported recurrent eye irritation due to the inward growth of eyelashes, which they treated themselves by eyelash removal (Fig. 1, III-2 , II-2, I-2, respectively). Furthermore, an extensive family history of eye irritation and eyelash removal was reported for the maternal side of the family (Fig. 1, individuals III-3 , III-4, II-2, II-4 and siblings of I-2 not shown in pedigree). A full brother (Fig. 1 , III-1) was unaffected by any of these aforementioned clinical conditions as verified by physical examination.
Physical examination of the proband showed microcephaly, with a head circumference measuring 48.9 cm (<5%). An additional row of small eyelashes and pits from eyelash removal were apparent upon visual examination of the patient, her mother and maternal grandmother (data not shown). In addition to distichiasis, vascular anomalies were apparent in the proband and are pictured in Figure 2A -F. The features of each lesion are described in Table II . The vascular anomalies were congenital and became more prominent with age. Some were macular (left chest, upper scalp) with blue and red colored vessels; others were deep blue, raised and soft in character. A skin biopsy was not obtained. An area of cutis aplasia was detected on the scalp to the left of the sagittal midline (10 Â 2 cm intracranial involvement. Chest MRI revealed cutaneous and subcutaneous vascular anomaly of the left mid and anterior chest without intrathoracic extension. MRI of the left leg revealed an infiltrative lesion (large arrows, Fig. 3A ) mainly within the soleus and flexor hallucis longus muscles, sparing the overlying distal medial gastrocnemius muscle and extending to the ankle. The intramuscular lesion is subtle and similar in signal intensity to the adjacent normal musculature. Mild enhancement was observed within the intramuscular lesion, which increased on later images and on coronal images (Fig. 3C,E ) the lesion appears composed of small vascular-like channels. The lesion extends into the adjacent subcutaneous fat (Fig. 3A-D, small arrows) , and this subcutaneous component also has the appearance of vascular-like channels. The overall appearance is most consistent with a vascular lesion, likely a VM. No histopathology was performed preventing exact identification of the ectatic vessels. Inheritance of the vascular malformations is uncertain, but the maternal grandmother of the proband had lower extremity varicosities and dilated superficial veins (Fig. 2,G) , and the father (Fig. 1, II-1) , who was unavailable for examination was reported by the maternal grandmother to have a prominent, discolored venous mass on his leg, larger than that observed in the proband. In addition, a similar leg mass was present in the paternal grandmother, who was also unavailable for examination.
Clinical Testing
Standard G-banded chromosomes of the proband showed a normal karyotype with no gross chromosomal abnormalities. Fragile X DNA testing was normal. Hereditary distichiasis can be inherited as a prominent feature of LD (OMIM 153400) and varicose veins are a less penetrant clinical manifestation associated with LD [Mellor et al., 2007] . Therefore, based on the presence of both distichiasis and vascular malformations, FOXC2 was tested for mutations. Sequencing of the single FOXC2 coding exon did not detect a mutation (data not shown). Likewise, FISH using BAC probe RP11-463O9 that spans the FOXC2 gene demonstrated that the genomic region surrounding and including the FOXC2 region was not deleted (Fig. 4) . The genome of the proband was also analyzed for copy number alterations by chromosomal BAC microarray analysis (CMA). CMA detected a deletion of BAC clone RP11-106D4 (Fig. 5) , which is located 745 kb distal to the FOXC2 locus. The RP11-106D4 deletion was also detected in the mother of the proband (Fig. 1, II-2 ), but was absent in her unaffected brother (Fig. 1, III-1) .
Identification of the 16q24.3 Deletion Breakpoint Junction
FISH was performed to confirm the 16q24.3 deletion in the proband. A FISH probe generated from BAC clone RP11-178L8, a clone that overlaps RP11-106D4, hybridized to only one copy of chromosome 16 on metaphase chromosomes from the proband confirming the deletion (Fig. 5A,C) . The size of the deletion was unknown due to the incomplete chromosome coverage of the BAC array. Therefore, BAC clones flanking RP11-106D4 and RP11-178L8 were also used as FISH probes. Proximal BAC clone RP11-235F18 and distal BAC clone RP11-482M8 both produced hybridization signals on both homologs of chromosome 16 roughly defining the size of the deletion (Fig. 5B,D) . To further refine the extent of the deletion, SNP genotyping was utilized to map a region of homozygosity surrounding the deletion. SNP genotypes from the 16q24.3 deletion region are summarized in Table I . rs1465452 and rs4843612 were the closest heterozygous SNPs flanking the deletion proximally and distally, respectively (Table I ; Fig. 5A ). Thus, rs1465452 and rs4843612 narrowed the 16q24.3 deletion to approximately 280 kb. To exactly determine the deletion boundaries, inverse PCR products were generated with primers distal to rs4843612, which were cloned and sequenced to identify the deletion breakpoint junction. Sequencing of one of the clones, MTB3-1-2, revealed the sequence of the 16q24.3 deletion breakpoint junction. There were 2 bp of homology at the breakpoints or any regions of extended homology in the 10 kb region flanking the breakpoints. The proximal and distal breaks occurred in an imperfect CAGAGA repeat sequence located at nucleotide positions 85,769,299 (NCBI Build 36) and in an old L1 retrotransposon (L1M2) at 86,034,334, respectively (Fig. 6A) . To confirm the positions of the breakpoints, genomic DNA isolated from a blood sample from the proband was used to PCR amplify the breakpoint region in both the wild type and 16q24.3 deletion allele (Fig. 6B) . The multiplex PCR assay generated both expected sizes for the wild type and 16q24.3 deletion alleles in the proband, whereas an unrelated control DNA generated PCR product corresponding to the wild type allele only. The deletion appears to result either from the simple ligation of proximal and distal DNA double strand breaks, consistent with formation by FIG. 3 . MRI imaging of the vascular anomalies of the proband. An infiltrative lesion (large arrows) is seen mainly within the soleus and flexor hallucis longus muscles, sparing the overlying distal medial gastrocnemius muscle. On T1 weighting (A), the intramuscular lesion is subtle and similar in signal intensity to the adjacent normal musculature. Scattered tiny areas of high signal may represent minimal fat within the lesion. On fluid sensitive sequences (B,D), the lesion is of high signal. After gadolinium is administered (C), there is mild enhancement within the intramuscular lesion, which increases on later images (E). Best seen on the coronal images (D,E), the lesion appears composed of small vascular-like channels. The lesion extends into the adjacent subcutaneous fat (A-D, small arrows). The subcutaneous component also has the appearance of vascular-like channels. The overall appearance is most consistent with a vascular lesion, likely a VM. The abnormality extends to the ankle (D, double arrows).
NHEJ or a template switching mechanism such as MMBIR and not from non-allelic homologous recombination (Fig. 6A) [Lieber et al., 2003; Hastings et al., 2009] . Identification of the breakpoints showed that the submicroscopic 16q24.3 deletion includes 265,046 bp of sequence (Fig. 6C) . The genes for C16ORF95, FBXO31 (F-box protein 31), and MAP1LC3B (microtubuleassociated protein 1 light chain 3 beta) and all but the first exon of the ZCCHC14 (zinc finger, CCHC domain containing 14) gene are deleted. In addition to these genes, the 16q24.3 deletion removes 115 kb of a gene desert located between FOXF1/FOXC2/FOXL1 gene cluster and C16ORF95.
Three CNVs in the 16q24.3 deletion region have been identified in the Database of Genomic Variants (Table III) . Two of the three CNVs (variation 4970 and 8283) include gains with no observed deletion. The distal 8 kb of the 16q24.3 deletion overlaps with a reported 168 kb deletion CNV, including the putative promoter region and first exon of ZCCHC14 [Wang et al., 2007] . Deletion of the centromeric 257 kb of the 16q24.3 deletion has not been detected in any reported CNV, or in any of >1,000 high-resolution chromosomal microarray cases in the Michigan Medical Genetics Laboratories at the University of Michigan to date (unpublished results).
GLMN and TIE2 Mutation Analysis
Physical evaluation of the vascular lesions in the proband ( Fig. 2 ; Table II) suggested that these lesions may be GVMs. Most VMs are sporadic, but hereditary VMCM and GVMs are caused by mutations in TIE2 and GLMN, respectively [Vikkula et al., 1996; Brouillard et al., 2002 Brouillard et al., , 2005 Wouters et al., 2010] . Allele-specific PCR demonstrated that the proband was heterozygous for the previously reported 157delAAGAA mutation (data not shown), whereas mutations were not detected in TIE2 [Vikkula et al., 1996; Brouillard et al., 2002] . Consequently, the vascular malformations of the proband are indeed GVMs.
DISCUSSION
We have presented the clinical and genomic characterization of an individual with distichiasis, microcephaly, mild intellectual impairment, but without lymphedema, associated with an inherited 16q24.3 deletion that includes the C16ORF95, FBXO31, MAP1LC3B, and ZCCHC14 genes as well as 115 kb of a gene desert The genomic sequence surrounding the proximal and distal breakpoints of the 16q24.3 deletion is shown above a sequencing chromatogram from the pMTB3-1-2 inverse PCR clone (deleted sequence is shaded). UCSC genome browser coordinates are shown above the sequence. Breakpoints are indicated by red lines. Deleted sequence is shown in lowercase whereas present sequence is shown in uppercase. B: Confirmation of 16q24 deletion breakpoints. A common forward primer (*) proximal to the 16q24 deletion in combination with reverse primers specific for the wild type allele (black) and the deletion allele (red) were used for PCR. The proband (P) was heterozygous for the 16q24 deletion whereas an unrelated control (C) was homozygous for the wild type allele. A control PCR reaction with no template was also performed (H). C: The 16q24 deletion removes C16ORF95, FBXO31, MAP1LC3B, and ZCCHC14 loci. The 16q24 region is shown as a black horizontal line with vertical lines representing exons and arrows showing the direction of the corresponding transcripts. The 16q24 deletion is depicted below by a red line.
distal to the FOXF1/FOXC2/FOXL1 loci. The uniqueness of this case is illustrated by the ability to differentiate it from other syndromes. Distichiasis, the anomalous growth of eyelashes from the meibomian glands, can be inherited in LD. The absence of both lymphedema and a FOXC2 coding mutation, as well as absence of many of the other LD-associated features argues against diagnoses of LD. Similarly, the presence of microcephaly, bilateral grade IV vesicoureteral reflux, and intellectual impairment has not been reported to be associated with LD [Erickson et al., 2001; Finegold et al., 2001; Brice et al., 2002] . The proband was originally referred not only for developmental delay and microcephaly, but also for evaluation of the vascular anomalies noted in Figure 2 and Table II . Boon et al. [2004] described criteria for the differentiation between VMs, CMVMs, and GVMs. GVMs have a cobblestoned appearance ranging in color from pink to purplish dark blue, consistent with characteristics of the proband's lesions. Mutation testing determined that the proband is heterozygous for a deleterious GLMN mutation resulting in numerous VMs that grossly are consistent with congenital GVMs. These VMs are distributed in many locations, although none were present in the oral mucosa and they did not blanch upon palpation, consistent with the characteristics of GVM. Although FOXC2 mutations have been associated with varicose veins, the presence of the GLMN mutation and resulting GVMs makes it impossible to discern the effect of the 16q24.3 deletion upon the vasculature of the proband [Ng et al., 2005; Mellor et al., 2007] . The patients of Stankiewicz (D2, D5, and D8) carried larger deletions including the region deleted here, and there was no apparent VMs described although these patients had a myriad of congenital anomalies and short lifespans making a direct comparison tenuous. The GLMN mutation status of the mother and maternal grandmother is unknown. The proband's father (unavailable for examination) was reported to have vascular anomalies similar to the proband, albeit a larger area of involvement on the leg. Consequently, the GLMN mutation most likely is responsible for vascular lesions of the proband and may have been inherited from her father, but it is uncertain whether the venous varicosities of other individuals on the maternal side of the family can be attributed to a GLMN mutation.
The absence of reports in the literature of 16q rearrangements producing 16q24.2-16q24.3 monosomy led to speculation that loss of this region is not tolerated [Callen et al., 1993] . More recently, Stankiewicz et al. [2009] have described individuals carrying large deletions that include the 16q24.3 deletion that we have delineated in this study. Two of these patients (designated D2 and D5) had dilated renal pelvices and bilateral renal pelviectasis, respectively. Similarly, our proband had bilateral grade IV vesicoureteral reflux requiring bilateral ureteral reimplantation surgery. Taken together these observations suggest that the 16q24.3 deletion may be responsible for the renal anomaly in the proband.
Haploinsufficiency of one or a combination of the genes removed by the 16q24.3 deletion could cause the non-vascular phenotypic features of the proband. ZCCHC14 encodes a completely uncharacterized zinc finger protein. The first two exons and putative promoter region of ZCCHC14 are deleted in a CNV (variation 4971, Database of Genomic Variants) in 8 of 95 normal control samples arguing that haploinsufficiency of ZCCHC14 does not have a phenotypic consequence [Wang et al., 2007] . Like ZCCHC14, C16ORF95, a recently annotated gene located centromeric to FBXO31, has no known function limiting the speculation of its role in the phenotypic features of the proband.
FBXO31 is an F-box protein that has been reported to function as a tumor suppressor in breast cancer cell lines by associating with a SCF (Skp1-Cdc53-F-box protein) ubiquitin complex to target substrates for degradation to progress through the cell cycle; however, no role in ocular, neural, or blood vascular development has been reported [Kumar et al., 2005] . Recently, FBXO31 was shown to target CYCLIND2 for degradation in response to DNA damage [Santra et al., 2009] .
MAP1LC3B is one of three genes (MAP1LC3A, MAP1LC3B, and MAP1LC3C) in the human genome homologous to the rat Map1lc3 and yeast Apg8 genes, both of which function in autophagy [He et al., 2003] . Conditional knockout of Atg5 and Atg7 has shown that impairment of autophagy leads to neurodegeneration in mice [Hara et al., 2006; Komatsu et al., 2006] . The accumulation of autophagic vesicles has also been found in a number of human neurodegenerative disorders including Parkinsonism and Huntington disease [Shintani and Klionsky, 2004] . Whether MAP1LC3B haploinsufficiency causes autophagic defects in humans is unknown and untested, but Map1lc3b transcripts are expressed in the central nervous system in mice during embryogenesis suggesting that MAP1LC3B is a candidate gene for the intellectual disability in our patient [Cann et al., 2008] .
There is no support for a role of any of the three deleted genes in development of distichiasis. The relative proximity of the 16q24.3 deletion to the FOXC2 locus, and the fact that FOXC2 haploinsufficiency causes distichiasis, suggests the possibility that FOXC2 may be involved via deletion of long-range cis-regulatory element(s) controlling FOXC2 expression. There are many examples for such effects. A large non-coding region or ''gene desert'' spanning 747 kb is located distally to the forkhead gene cluster that includes FOXF1, FOXC2, and FOXL1. Conserved non-coding elements in gene deserts have been shown to have enhancer function in transgenic experiments [Nobrega et al., 2003] . Mapping the breakpoints of a balanced translocation (Y;16) to this region in a congenital lymphedema patient led to identification of FOXC2 mutations in LD families [Erickson et al., 1995; Fang et al., 2000] . The chromosome 16 translocation breakpoint occurred 120 kb telomeric to the FOXC2 locus suggesting that removal of chromosome 16 distal to the breakpoint and/or the addition of the Y chromosome disrupted FOXC2 expression. In our case, the 265 kb deletion is located 609 kb telomeric to FOXC2 and removes 151 kb of the gene desert. Therefore, the 16q24.3 deletion could remove cis regulatory element(s) responsible for FOXC2 expression in the developing eyelid, a site of normal Foxc2 expression during development [Kaestner et al., 1996; Iida et al., 1997; Winnier et al., 1997; Pressman et al., 2000; Dagenais et al., 2004] .
In summary, we have precisely mapped a submicroscopic contiguous gene deletion in chromosome 16q24.3 in an individual with distichiasis, microcephaly, bilateral grade IV vesicoureteral reflux, and mild intellectual impairment, who also has congenital GVMs caused by a deleterious GLMN gene mutation. The 16q24.3 deletion causes haploinsufficiency of four genes, C16ORF95, FBXO31, MAP1LC3B, and ZCCHC14, and removes 115 kb of a gene desert distal to the forkhead gene cluster on chromosome 16. The nonvascular phenotypic features of the proband may result from haploinsufficiency of the deleted genes and/or by disruption of regulation of FOXC2 or other nearby gene expression.
